The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models
暂无分享,去创建一个
Clara D. Christ | E. Nevedomskaya | H. Briem | Andreas Hägebarth | P. Lienau | B. Haendler | D. Mumberg | M. Bauser | C. Lemos | B. Bader | F. von Nussbaum | T. Heinrich | Simon J. Baumgart | S. Holton | U. Bömer | C. Nising | Lara Kuhnke | V. Schulze | J. Lefranc